SCHEMBL5528655

SCHEMBL5528655

CC(C)(C)c1nc(Cc2cccc(C(F)(F)F)c2)c(C(=O)O)s1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
GPR52 Q9Y2T5 8/20 0.45
MAPT P10636 2/20 0.43
CSNK1D P48730 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SCD O00767 3/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NR4A2 P43354 1/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5527688 0.88 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2GPR52MAPTMEN1
SCHEMBL5521998 0.86 HCAR2 (0.46) ALDH1A1SMN1; SMN2GPR52MAPTNPC1
SCHEMBL5528374 0.85 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5528442 0.84 NR1H4 (0.43) SMN1; SMN2NR4A2RAB9A
SCHEMBL5527532 0.84 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5522180 0.83 HCAR2 (0.46) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5520198 0.82 RXFP1 (0.45) ALDH1A1GPR52MAPTCSNK1DCYP1A2
SCHEMBL5527759 0.81 DHFR (0.48) ALDH1A1SMN1; SMN2NR4A2
SCHEMBL5520215 0.81 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2MAPTCSNK1DNPC1
SCHEMBL5522334 0.80 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2GPR52MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS POLI, POLB, POLA1 ALDH1A1 2042/4885SMN1; SMN2 4646/4885GPR52 2835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.